3 New Papers: Keto's Hidden LPS Spike, Exercise Overhauls Cholesterol in Older Women, and a 47-Minute Sleep Fix for Teens

3 New Papers: Keto's Hidden LPS Spike, Exercise Overhauls Cholesterol in Older Women, and a 47-Minute Sleep Fix for Teens

Three PubMed papers indexed May 28–June 4, 2026: a 12-week RCT (n=90) finds keto + caloric restriction cuts body fat 21.7% and insulin resistance in prediabetes, but significantly raises LPS (a gut-derived inflammatory marker); a 23-RCT meta-analysis shows supervised exercise cuts total cholesterol 26.7 mg/dL and systolic BP 8.35 mmHg in older women; and a 2-week RCT in 86 adolescents finds a personalized sleep schedule + morning bright light + amber glasses gains 47 minutes of weeknight sleep and shifts circadian timing 45 minutes earlier.

Daily Nutrition Science Digest
2026/6/4 · 16:10
購読 1 件 · コンテンツ 9 件

リサーチノート

Today's three papers from PubMed (indexed May 28–June 4, 2026) carry a combined message worth sitting with: dietary changes that improve one set of markers can quietly worsen another; exercise is one of the most reliable metabolic levers available for older women; and a two-week behavioral reset can add nearly an hour of sleep per night for chronically sleep-deprived teenagers.

1. Nutrition: keto cuts insulin resistance but raises a gut-derived inflammatory marker

Study: "Effects of the ketogenic-caloric restricted diet on metabolic endotoxemia and metabolic health in adults with prediabetes: A randomized controlled trial" Citation: Jawamis A, Al-Domi H, Sarayreh NA. Nutrition. 2026 Jun (Epub Jan 23, 2026). PMID 41747400. DOI 10.1016/j.nut.2026.113119
Design & sample: 90 adults with obesity and prediabetes, randomized 1:1:1 to (a) ketogenic diet + caloric restriction (KD+CR), (b) normal diet + caloric restriction (ND+CR), or (c) normal diet without restriction (ND). Measured at baseline and 12 weeks. Peer-reviewed, published in Nutrition.1
Core findings: The KD+CR arm delivered by far the largest metabolic improvements. Body weight dropped 10.5% (vs. 3.9% and 4.5% in the two comparators), body fat mass fell 21.7%, insulin dropped to 12.0 μIU/mL (vs. 19.3 in the unrestricted group), and HOMA-IR fell to 2.9 (vs. 4.7). IL-6 — a pro-inflammatory cytokine — declined significantly in KD+CR vs. the normal diet. By almost every metabolic marker, keto + caloric restriction was the clear winner at 12 weeks.1
The catch: serum lipopolysaccharide (LPS) — a bacterial endotoxin released when gut bacteria die — was significantly higher in the KD+CR group at 12 weeks (158.6 pg/mL vs. 129.6 and 126.7 in the two comparators, p = 0.004). LPS at elevated levels is associated with low-grade systemic inflammation and is referred to as "metabolic endotoxemia." The authors note that this likely reflects ketosis-driven shifts in gut microbiome composition, and that the long-term consequences of sustained LPS elevation remain unknown.1
Conflicts of interest: None declared.
Actionable takeaway: If you are doing a strict ketogenic diet with caloric restriction for prediabetes or weight loss, the short-term metabolic gains are real and substantial. But the gut microbiome signal warrants attention: consider cycling in more prebiotic fiber (legumes, vegetables, resistant starch on re-feed days) or monitoring LPS-related inflammatory markers if doing extended keto. Discuss duration with a clinician — particularly if you already have elevated inflammation at baseline.
コンテンツカードを読み込んでいます…

2. Exercise: aerobic + resistance training rewrites lipid and cardiovascular risk profiles in older women

Study: "Effects of exercise on metabolic risk, cardiovascular fitness, and body composition in elderly women of the past decade: a systematic review and meta-analysis" Citation: Shen J, Peng J, Luan Y, Liu X, Li J, Wu J. J Int Soc Sports Nutr. 2026 Dec 31 (Epub Jun 2, 2026). PMID 42228407. DOI 10.1080/15502783.2026.2675444
Design & sample: Systematic review and meta-analysis of 23 RCTs (33 intervention arms, 23 controls) from 2014–2024 involving healthy elderly women. PRISMA-compliant. Peer-reviewed, published in Journal of the International Society of Sports Nutrition.2
Core findings: Supervised exercise — aerobic, resistance, or combined — produced statistically significant improvements across five cardiovascular and metabolic markers:2
OutcomeChange (exercise vs. control)
Total cholesterol (TC)−26.67 mg/dL (95% CI: −34.92 to −18.42)
LDL cholesterol−23.77 mg/dL (95% CI: −34.48 to −13.05)
Triglycerides−8.56 mg/dL (95% CI: −16.72 to −0.40)
VO₂peak+2.78 mL/kg/min (95% CI: 1.87 to 3.70)
Systolic blood pressure−8.35 mmHg
Body fat percentage−2.47% (95% CI: −3.42 to −1.53)
Blood glucose dropped −5.59 mg/dL; C-reactive protein fell −0.86 mg/L. Notably, total body weight, waist circumference, and skeletal muscle mass did not change significantly — meaning exercise remodeled composition and metabolic function without necessarily moving the scale. Evidence certainty was rated moderate for TC, triglycerides, body fat, VO₂peak, and SBP.
Conflicts of interest: Not explicitly disclosed.
Actionable takeaway: For women over 60, regular supervised exercise is not optional maintenance — it actively moves major cardiovascular risk markers. A 26 mg/dL drop in total cholesterol rivals statin effect sizes in some populations. The benefit is consistent regardless of exercise type, though combined aerobic + resistance protocols appeared in many of the higher-effect arms. If you are in or near this demographic, the argument for structured gym programming rather than unstructured walking becomes harder to dismiss.
コンテンツカードを読み込んでいます…

3. Sleep: two weeks of scheduling, morning light, and amber glasses gained 47 minutes of weeknight sleep in adolescents

Study: "Chronotherapeutic Approaches to Target Insufficient and Late Sleep in Adolescents: A Randomized Clinical Trial" Citation: Wescott DL, Quick AD, Oryshkewych NS, et al. JAMA Pediatrics. 2026 Jun 1. PMID 42008244. DOI 10.1001/jamapediatrics.2026.0976
Design & sample: 86 adolescents aged 16–19 at an academic medical center, randomized to the "Sleeping Late Teens Program" (n=40) or sleep monitoring control (n=40). Intervention consisted of one problem-solving session (~1 hour), a personalized 2-week sleep schedule with gradual earlier bedtimes and wake times, morning bright-light glasses (30–60 min on waking), and amber-tinted blue-light-blocking glasses (2 hours before bed). Primary outcomes: weeknight circadian timing (dim-light melatonin onset, DLMO), weeknight sleep duration (actigraphy), and DLMO–midsleep alignment. Intention-to-treat analysis. Published in JAMA Pediatrics.3
Core findings: The intervention group gained 47 minutes of weeknight sleep compared with controls (β = 0.74; 95% CI, 0.30–1.18; p = 0.003). Circadian timing shifted 45 minutes earlier (β = −0.55; 95% CI, −0.79 to −0.31; p = 0.003), meaning participants' biological clocks moved closer into alignment with school start times. The DLMO–midsleep interval (a measure of circadian alignment) shortened by 18 minutes in the intervention group vs. an 8-minute lengthening in controls, but the difference was not statistically significant. All of this happened after just two weeks — with a combined intervention that included low-cost hardware (glasses) and a single guided session.3
Conflicts of interest: Dr. Wallace receives personal fees from Noctem Health and HealthRhythms; Dr. Buysse receives consulting fees from Sleep Number, Synchronicity Pharma, and Google Health, and royalties from sleep questionnaires. Dr. Hasler received NIH NIDA grants during the study. No other disclosures.
Actionable takeaway: For teenagers (or parents of teenagers) dealing with chronic night-owl sleep patterns, this trial gives a practical protocol: personalize bedtime/wake times to shift earlier, add morning bright light immediately on waking, and block blue light in the 2 hours before bed. The gains here — 47 minutes of added sleep per night — are large enough to meaningfully affect alertness, mood, and school performance. The trial was short-term; it's not yet known whether gains persist after the 2-week window, making habit formation critical.

Coverage window: PubMed publication dates May 28–June 4, 2026. All three papers involve human participants only.

このコンテンツについて、さらに観点や背景を補足しましょう。

  • ログインするとコメントできます。